Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 19 |
NetGPI | no | yes: 0, no: 19 |
Term | Name | Level | Count |
---|---|---|---|
GO:0020022 | acidocalcisome | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: A4H9Y8
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 14 |
GO:0043167 | ion binding | 2 | 13 |
GO:0043169 | cation binding | 3 | 13 |
GO:0046872 | metal ion binding | 4 | 13 |
GO:0003824 | catalytic activity | 1 | 1 |
GO:0004842 | ubiquitin-protein transferase activity | 4 | 1 |
GO:0016740 | transferase activity | 2 | 1 |
GO:0019787 | ubiquitin-like protein transferase activity | 3 | 1 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 1 |
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003723 | RNA binding | 4 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 170 | 174 | PF00656 | 0.446 |
CLV_C14_Caspase3-7 | 64 | 68 | PF00656 | 0.528 |
CLV_NRD_NRD_1 | 117 | 119 | PF00675 | 0.315 |
CLV_NRD_NRD_1 | 144 | 146 | PF00675 | 0.452 |
CLV_NRD_NRD_1 | 376 | 378 | PF00675 | 0.485 |
CLV_NRD_NRD_1 | 71 | 73 | PF00675 | 0.564 |
CLV_NRD_NRD_1 | 88 | 90 | PF00675 | 0.582 |
CLV_PCSK_KEX2_1 | 144 | 146 | PF00082 | 0.404 |
CLV_PCSK_KEX2_1 | 71 | 73 | PF00082 | 0.533 |
CLV_PCSK_KEX2_1 | 88 | 90 | PF00082 | 0.534 |
CLV_PCSK_SKI1_1 | 49 | 53 | PF00082 | 0.492 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.673 |
DEG_SCF_FBW7_1 | 217 | 222 | PF00400 | 0.488 |
DOC_MAPK_MEF2A_6 | 246 | 253 | PF00069 | 0.425 |
DOC_USP7_MATH_1 | 333 | 337 | PF00917 | 0.716 |
DOC_USP7_MATH_1 | 343 | 347 | PF00917 | 0.656 |
DOC_USP7_MATH_2 | 353 | 359 | PF00917 | 0.488 |
DOC_USP7_UBL2_3 | 119 | 123 | PF12436 | 0.567 |
DOC_WW_Pin1_4 | 13 | 18 | PF00397 | 0.551 |
DOC_WW_Pin1_4 | 215 | 220 | PF00397 | 0.483 |
LIG_14-3-3_CanoR_1 | 282 | 292 | PF00244 | 0.530 |
LIG_14-3-3_CanoR_1 | 40 | 48 | PF00244 | 0.595 |
LIG_14-3-3_CanoR_1 | 71 | 80 | PF00244 | 0.553 |
LIG_DLG_GKlike_1 | 377 | 385 | PF00625 | 0.485 |
LIG_FHA_1 | 1 | 7 | PF00498 | 0.432 |
LIG_FHA_1 | 109 | 115 | PF00498 | 0.474 |
LIG_FHA_1 | 132 | 138 | PF00498 | 0.480 |
LIG_FHA_1 | 14 | 20 | PF00498 | 0.536 |
LIG_FHA_1 | 153 | 159 | PF00498 | 0.462 |
LIG_FHA_1 | 22 | 28 | PF00498 | 0.470 |
LIG_FHA_1 | 242 | 248 | PF00498 | 0.402 |
LIG_FHA_1 | 366 | 372 | PF00498 | 0.484 |
LIG_FHA_2 | 127 | 133 | PF00498 | 0.439 |
LIG_FHA_2 | 284 | 290 | PF00498 | 0.576 |
LIG_GBD_Chelix_1 | 44 | 52 | PF00786 | 0.452 |
LIG_LIR_Apic_2 | 218 | 224 | PF02991 | 0.487 |
LIG_LIR_Gen_1 | 57 | 63 | PF02991 | 0.544 |
LIG_LIR_Nem_3 | 262 | 268 | PF02991 | 0.393 |
LIG_LIR_Nem_3 | 57 | 62 | PF02991 | 0.547 |
LIG_LIR_Nem_3 | 67 | 73 | PF02991 | 0.543 |
LIG_LRP6_Inhibitor_1 | 272 | 278 | PF00058 | 0.380 |
LIG_NRBOX | 145 | 151 | PF00104 | 0.505 |
LIG_NRBOX | 26 | 32 | PF00104 | 0.530 |
LIG_PTB_Apo_2 | 264 | 271 | PF02174 | 0.411 |
LIG_PTB_Phospho_1 | 264 | 270 | PF10480 | 0.429 |
LIG_SH2_CRK | 221 | 225 | PF00017 | 0.504 |
LIG_SH2_CRK | 234 | 238 | PF00017 | 0.544 |
LIG_SH2_CRK | 299 | 303 | PF00017 | 0.534 |
LIG_SH2_CRK | 59 | 63 | PF00017 | 0.443 |
LIG_SH2_CRK | 70 | 74 | PF00017 | 0.461 |
LIG_SH2_GRB2like | 299 | 302 | PF00017 | 0.555 |
LIG_SH2_NCK_1 | 234 | 238 | PF00017 | 0.497 |
LIG_SH2_SRC | 299 | 302 | PF00017 | 0.546 |
LIG_SH2_SRC | 90 | 93 | PF00017 | 0.502 |
LIG_SH2_STAP1 | 270 | 274 | PF00017 | 0.420 |
LIG_SH2_STAP1 | 381 | 385 | PF00017 | 0.490 |
LIG_SH2_STAT3 | 12 | 15 | PF00017 | 0.499 |
LIG_SH2_STAT3 | 125 | 128 | PF00017 | 0.539 |
LIG_SH2_STAT5 | 103 | 106 | PF00017 | 0.450 |
LIG_SH2_STAT5 | 113 | 116 | PF00017 | 0.407 |
LIG_SH2_STAT5 | 221 | 224 | PF00017 | 0.490 |
LIG_SH2_STAT5 | 356 | 359 | PF00017 | 0.485 |
LIG_SH3_3 | 153 | 159 | PF00018 | 0.666 |
LIG_SH3_3 | 291 | 297 | PF00018 | 0.587 |
LIG_SH3_3 | 90 | 96 | PF00018 | 0.390 |
LIG_TRAF2_1 | 129 | 132 | PF00917 | 0.464 |
LIG_WW_1 | 353 | 356 | PF00397 | 0.494 |
MOD_CK1_1 | 126 | 132 | PF00069 | 0.483 |
MOD_CK1_1 | 235 | 241 | PF00069 | 0.543 |
MOD_CK1_1 | 346 | 352 | PF00069 | 0.670 |
MOD_CK1_1 | 380 | 386 | PF00069 | 0.727 |
MOD_CK2_1 | 126 | 132 | PF00069 | 0.461 |
MOD_CK2_1 | 283 | 289 | PF00069 | 0.577 |
MOD_CK2_1 | 355 | 361 | PF00069 | 0.668 |
MOD_CK2_1 | 44 | 50 | PF00069 | 0.519 |
MOD_GlcNHglycan | 197 | 200 | PF01048 | 0.641 |
MOD_GlcNHglycan | 207 | 210 | PF01048 | 0.498 |
MOD_GlcNHglycan | 227 | 231 | PF01048 | 0.668 |
MOD_GlcNHglycan | 348 | 351 | PF01048 | 0.674 |
MOD_GlcNHglycan | 382 | 385 | PF01048 | 0.736 |
MOD_GlcNHglycan | 74 | 77 | PF01048 | 0.316 |
MOD_GSK3_1 | 108 | 115 | PF00069 | 0.428 |
MOD_GSK3_1 | 119 | 126 | PF00069 | 0.477 |
MOD_GSK3_1 | 167 | 174 | PF00069 | 0.716 |
MOD_GSK3_1 | 191 | 198 | PF00069 | 0.547 |
MOD_GSK3_1 | 213 | 220 | PF00069 | 0.601 |
MOD_GSK3_1 | 72 | 79 | PF00069 | 0.482 |
MOD_GSK3_1 | 97 | 104 | PF00069 | 0.430 |
MOD_N-GLC_1 | 139 | 144 | PF02516 | 0.440 |
MOD_N-GLC_1 | 333 | 338 | PF02516 | 0.772 |
MOD_NEK2_1 | 167 | 172 | PF00069 | 0.625 |
MOD_NEK2_1 | 283 | 288 | PF00069 | 0.481 |
MOD_NEK2_1 | 44 | 49 | PF00069 | 0.418 |
MOD_OFUCOSY | 281 | 287 | PF10250 | 0.564 |
MOD_PIKK_1 | 11 | 17 | PF00454 | 0.666 |
MOD_PIKK_1 | 123 | 129 | PF00454 | 0.406 |
MOD_PIKK_1 | 21 | 27 | PF00454 | 0.591 |
MOD_PIKK_1 | 333 | 339 | PF00454 | 0.594 |
MOD_PKA_1 | 377 | 383 | PF00069 | 0.484 |
MOD_PKA_2 | 117 | 123 | PF00069 | 0.600 |
MOD_PKA_2 | 346 | 352 | PF00069 | 0.664 |
MOD_PKA_2 | 39 | 45 | PF00069 | 0.592 |
MOD_Plk_1 | 108 | 114 | PF00069 | 0.431 |
MOD_Plk_1 | 139 | 145 | PF00069 | 0.457 |
MOD_Plk_1 | 213 | 219 | PF00069 | 0.479 |
MOD_Plk_1 | 261 | 267 | PF00069 | 0.436 |
MOD_Plk_2-3 | 101 | 107 | PF00069 | 0.431 |
MOD_Plk_2-3 | 355 | 361 | PF00069 | 0.488 |
MOD_ProDKin_1 | 13 | 19 | PF00069 | 0.546 |
MOD_ProDKin_1 | 215 | 221 | PF00069 | 0.485 |
TRG_ENDOCYTIC_2 | 59 | 62 | PF00928 | 0.426 |
TRG_ENDOCYTIC_2 | 70 | 73 | PF00928 | 0.437 |
TRG_ENDOCYTIC_2 | 90 | 93 | PF00928 | 0.403 |
TRG_ER_diArg_1 | 143 | 145 | PF00400 | 0.444 |
TRG_ER_diArg_1 | 70 | 72 | PF00400 | 0.531 |
TRG_ER_diArg_1 | 87 | 89 | PF00400 | 0.512 |
TRG_NES_CRM1_1 | 148 | 160 | PF08389 | 0.635 |
TRG_Pf-PMV_PEXEL_1 | 112 | 116 | PF00026 | 0.500 |
TRG_Pf-PMV_PEXEL_1 | 144 | 148 | PF00026 | 0.432 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I1I4 | Leptomonas seymouri | 63% | 99% |
A0A0N1PG85 | Leptomonas seymouri | 31% | 100% |
A0A0S4KEK3 | Bodo saltans | 35% | 100% |
A0A1X0P6E1 | Trypanosomatidae | 37% | 100% |
A0A1X0P6N8 | Trypanosomatidae | 33% | 78% |
A0A3Q8IA61 | Leishmania donovani | 32% | 100% |
A0A3R7RSV6 | Trypanosoma rangeli | 36% | 100% |
A0A3S7WVD2 | Leishmania donovani | 74% | 100% |
A0A422P3A2 | Trypanosoma rangeli | 39% | 96% |
A4H9Y7 | Leishmania braziliensis | 32% | 100% |
A4HY39 | Leishmania infantum | 74% | 100% |
A4HY52 | Leishmania infantum | 32% | 100% |
D0A0F7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 39% | 91% |
E9ARY1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 34% | 100% |
E9ARY2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 71% | 100% |
Q4QDJ1 | Leishmania major | 34% | 100% |
V5BSB1 | Trypanosoma cruzi | 36% | 82% |
V5BWY8 | Trypanosoma cruzi | 36% | 100% |